University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 1 of 23
Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation
NCT07661433
IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study
NCT07596888
Early Dental Risk Screening for Pediatric Sleep-Disordered Breathing
NCT07581938
Recovering Sleep After Trauma
NCT07196332
UNC Tobacco Convenience Store
NCT07458607
CARED : A Novel Rapid Treatment Paradigm for Depression
NCT07507370
Mind Your Heart Intervention for American Indian Women
NCT07581899
GLOW Study: Effects of Triple Protein in Women
NCT07526571
Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)
NCT07337902
CommunityRx-Kidney Health
NCT07237295
BXCL501 After Stress to Increase Recovery Success
NCT06943404
Sugary Drink Labeling Study
NCT07294053
Impacts of Sugar Warnings on Weight Bias
NCT07346001
Neural Mechanisms of Light Driven Analgesia
NCT07245303
Interscalene vs Phrenic-sparing Blocks in Obesity and Effect of Maximum Inspiratory Pressure
NCT07216820
RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)
NCT07322302
Sensory Spinal Cord Stimulation
NCT07095036
REAL-Fam Feasibility Study for Youth Diabetes Management
NCT07212790
Modulation of Brain Rhythms in Stroke
NCT07121582
mHealth for Early Psychosis Caregivers in Statewide Program Outreach
NCT07225179
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
NCT07237516
Mindful Miles Pilot Feasibility Study
NCT07462429
Immersive Physical Therapy in the Neonatal Intensive Care Unit (NICU)
NCT06927037
COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
NCT07198113
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
NCT07213635
Co-Designing a Virtual Reality Intervention to Enhance Skill Development
NCT07186543
The DART DELIVER-02 Study
NCT07217379
Woodsmoke Exposure, Influenza Infection, and Nasal Immunity
NCT06841913
Healthy Living Anson Study
NCT07126587
Affect-based Impulsivity in Borderline Personality Disorder
NCT06880640
Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine
NCT07148713
Caring for the Carer
NCT07167641
Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema
NCT07095361
Caring Connections Youth Suicide Detection and Intervention Study
NCT06353711
Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS)
NCT06979154
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
NCT06864403
Comparing a Workplace Resilience and a Physical Activity Intervention on Early Childhood Educators Well-being
NCT06919952
Microplastic Exposure From Clear Aligner Wear (MPE)
NCT06934603
Anterior Cruciate Ligaments: Studying Updates in neuroCognition After Knee Manipulation
NCT07058467
Resources for Optimizing Outcomes in Toddlers on the Spectrum
NCT07086781
Preventing Type 2 Diabetes in Black Emergent Adult
NCT06848244
A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™
NCT06649890
Frailty and Muscle Strength Tests in Older Adults Undergoing Major Surgery
NCT06988176
19F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease
NCT06066723
Concentration of n-3 PUFA Monohydroxylated Derivatives in Adults With Obesity After n-3 PUFA Supplementation.
NCT06991296
Mirikizumab Real World Protocol
NCT06696014
Improving Parental Support in Hypospadias Care
NCT06832280
Alcohol Labeling Study
NCT06835920
Neuroscience of Psychotherapy for Depression
NCT06696001
Connect-Home: Alzheimer's Disease and Related Dementias
NCT06840587
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets.Report a data error.